Renalytix Plc (LON:RENX – Get Free Report) fell 4.9% during mid-day trading on Wednesday . The company traded as low as GBX 9.70 ($0.13) and last traded at GBX 9.75 ($0.13). 72,211 shares changed hands during trading, a decline of 86% from the average session volume of 509,517 shares. The stock had previously closed at GBX 10.25 ($0.13).
Renalytix Price Performance
The stock’s fifty day moving average price is GBX 12.75 and its 200-day moving average price is GBX 21.15. The firm has a market cap of £15.76 million, a price-to-earnings ratio of -32.79 and a beta of 2.10. The company has a current ratio of 0.42, a quick ratio of 2.42 and a debt-to-equity ratio of 173.95.
Renalytix Company Profile
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from electronic health record systems to generate a unique patient risk score.
Read More
- Five stocks we like better than Renalytix
- What Do S&P 500 Stocks Tell Investors About the Market?
- Powering Your Portfolio: The Utility Sector’s Electrifying Surge
- What is the NASDAQ Stock Exchange?
- Adobe Stock Builds Long-Term Value: Consider Buying on the Dip
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Albemarle Jumps as Lithium Stock Buying Frenzy Takes Off
Receive News & Ratings for Renalytix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Renalytix and related companies with MarketBeat.com's FREE daily email newsletter.
